Page last updated: 2024-10-28

hydroxychloroquine and Cutaneous T-Cell Lymphoma

hydroxychloroquine has been researched along with Cutaneous T-Cell Lymphoma in 2 studies

Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Molinelli, E1
Campanati, A1
Brisigotti, V1
Diotallevi, F1
Radi, G1
Racchini, S1
Giangiacomi, M1
Offidani, A1
Amann, VC1
Dreier, J1
Ignatova, D1
Kamarashev, J1
Kerl, K1
Kempf, W1
Pascolo, S1
Dummer, R1
Cozzio, A1
Guenova, E1

Reviews

1 review available for hydroxychloroquine and Cutaneous T-Cell Lymphoma

ArticleYear
Familial lupus panniculitis: two cases, same diagnosis, what evolution?
    Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia, 2020, Volume: 155, Issue:6

    Topics: Adult; Biomarkers; Biopsy; Diagnosis, Differential; Drug Therapy, Combination; Female; Humans; Hydro

2020

Other Studies

1 other study available for hydroxychloroquine and Cutaneous T-Cell Lymphoma

ArticleYear
Disseminated Primary Cutaneous CD8+ Small/Medium-sized Pleomorphic T-cell Lymphoma Responding to Hydroxychloroquine.
    Acta dermato-venereologica, 2015, Volume: 95, Issue:5

    Topics: Antimalarials; Biopsy, Needle; CD8 Antigens; Dose-Response Relationship, Drug; Drug Administration S

2015